Literature DB >> 11999898

Regional cerebral blood flow in deficit/nondeficit types of schizophrenia according to SDS criteria.

Guillaume Vaiva1, Olivier Cottencin, Pierre Michel Llorca, Patrick Devos, Sylvie Dupont, Olivier Mazas, Claire Rascle, Pierre Thomas, Marc Steinling, Michel Goudemand.   

Abstract

A relationship between "hypofrontality" and a negative form of schizophrenia is commonly found. The Schedule for the Deficit Syndrome (SDS) provides specific criteria for assessing the presence of negative symptoms, their duration and whether the symptoms are primary or secondary. The purpose of our study was to compare the regional cerebral blood flow (rCBF) at rest, in 62 deficit and nondeficit schizophrenic patients, according to the SDS criteria (French version). The deficit patients in our population were comparable to those described in the literature (stability of their negative symptoms with time, poor premorbid adjustment, duration of the illness, age at the first episode, etc.). No difference was found in the locoregional perfusion with respect to the DSM-III-R type of schizophrenia, the sex or the type of treatment received. The patients with a deficit form of schizophrenia showed a significant bilateral reduction in single photon emission computed tomography (SPECT) perfusion in the right frontodorsolateral cortex (P=.0105) and the left frontodorsolateral cortex (P=.0004) compared with the nondeficit schizophrenic patients. The contribution of SDS seems to be helpful in distinguishing between significant cerebral characteristics in deficit schizophrenics, as defined by Carpenter. These results suggest a decrease in prefrontal perfusion at rest, which corresponds with neuropsychological data.

Entities:  

Mesh:

Year:  2002        PMID: 11999898     DOI: 10.1016/s0278-5846(01)00292-5

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  11 in total

1.  Altered probabilistic learning and response biases in schizophrenia: behavioral evidence and neurocomputational modeling.

Authors:  James A Waltz; Michael J Frank; Thomas V Wiecki; James M Gold
Journal:  Neuropsychology       Date:  2011-01       Impact factor: 3.295

Review 2.  rTMS strategies for the study and treatment of schizophrenia: a review.

Authors:  Arielle D Stanford; Zafar Sharif; Cheryl Corcoran; Nina Urban; Dolores Malaspina; Sarah H Lisanby
Journal:  Int J Neuropsychopharmacol       Date:  2008-02-01       Impact factor: 5.176

3.  The factorial structure of the schedule for the deficit syndrome in schizophrenia.

Authors:  David Kimhy; Scott Yale; Raymond R Goetz; Lynn Marcinko McFarr; Dolores Malaspina
Journal:  Schizophr Bull       Date:  2005-09-21       Impact factor: 9.306

4.  Validity of a 'proxy' for the deficit syndrome derived from the Positive And Negative Syndrome Scale (PANSS).

Authors:  Raymond R Goetz; Cheryl Corcoran; Scott Yale; Arielle D Stanford; David Kimhy; Xavier Amador; Dolores Malaspina
Journal:  Schizophr Res       Date:  2007-04-12       Impact factor: 4.939

Review 5.  Neurobiological background of negative symptoms.

Authors:  Silvana Galderisi; Eleonora Merlotti; Armida Mucci
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-03-24       Impact factor: 5.270

6.  Beneficial effect of atypical antipsychotics on prefrontal brain function in acute psychotic disorders.

Authors:  Ann-Christine Ehlis; Jürgen Zielasek; Martin J Herrmann; Thomas Ringel; Christian Jacob; Andreas J Fallgatter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-01-07       Impact factor: 5.270

Review 7.  The functional neuroanatomy of symptom dimensions in schizophrenia: a qualitative and quantitative review of a persistent question.

Authors:  Vina M Goghari; Scott R Sponheim; Angus W MacDonald
Journal:  Neurosci Biobehav Rev       Date:  2009-09-20       Impact factor: 8.989

8.  Deficit schizophrenia: an update.

Authors:  Brian Kirkpatrick; Silvana Galderisi
Journal:  World Psychiatry       Date:  2008-10       Impact factor: 49.548

Review 9.  Theories of schizophrenia: a genetic-inflammatory-vascular synthesis.

Authors:  Daniel R Hanson; Irving I Gottesman
Journal:  BMC Med Genet       Date:  2005-02-11       Impact factor: 2.103

10.  Efficacy Towards Negative Symptoms and Safety of Repetitive Transcranial Magnetic Stimulation Treatment for Patients with Schizophrenia: A Systematic Review.

Authors:  Junjie Wang; Yingqun Zhou; Hong Gan; Jiaoyan Pang; Hui Li; Jijun Wang; Chunbo Li
Journal:  Shanghai Arch Psychiatry       Date:  2017-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.